biovu

October 7, 2016

Rheumatoid subtypes explored by PheWAS

A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.

By Paul Govern
Vanderbilt University Medical Center (Vanderbilt University)
July 7, 2016

VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source.

By Bill Snyder
July 7, 2016

VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced.

By Bill Snyder
DNA sequence visualization
April 4, 2016

VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.

By Bill Snyder
December 10, 2015

Genetics Institute director Cox set for next Discovery Lecture

Nancy Cox, Ph.D., founding director of the Vanderbilt Genetics Institute, will deliver the next Flexner Discovery Lecture on Thursday, Dec. 17.

By Leigh MacMillan
genetic sequence
August 6, 2015

Genotyping project to be an ‘engine of discovery’

Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known.

By Bill Snyder
January 29, 2015

Consent process for BioVU participation updated

As of last week, Vanderbilt has updated the process used to facilitate patient participation in BioVU, the Medical Center’s DNA repository.
By Paul Govern
November 6, 2014

BioVU to collect plasma in hunt for heart failure clues

Vanderbilt’s biobank, BioVU, has begun to collect and store plasma, the liquid part of blood, to aid studies of diseases ranging from heart failure and hypertension to breast cancer.
By Bill Snyder
September 26, 2014

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.
By Leigh MacMillan
July 10, 2014

VU, Celgene announce research partnership

Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.
By Bill Snyder
June 12, 2014

Roden named to NIH’s genomics advisory council

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).
By Bill Snyder
March 31, 2014

E-records shed light on drug response

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.
By Leigh MacMillan
January 10, 2014

A pain in the … genes

Vanderbilt researchers have discovered that variation in the gene encoding the potassium channel GIRK1 plays a role in modulating human pain perception.
By Leigh MacMillan